1Castera L. Invasive and non-invasive methods for the assessment of fibro- sis and disease progression in chronic liver disease [ J ]. Best Pract Res Clin Gastroentero1,2011,25 (2) :291 - 303.
2Patel KD, Abeysekera KW, Marlais M, et al. Recent advances in imaging hepatic fibrosis and steatosis [ J ]. Expert Rev Gastroenterol Hepatol, 2011,5(1) :91 -104.
6Lesmana CR, Salim S, Hasan I, et al. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B : the role in primary care setting [ J ]. J Clin Pathol, 2011,64 ( 10 ) : 916 - 20.
9Razek AA, Abdalla A, Omran E, et al. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging[ J]. Eur J Radiol,2011,78( 1 ) :129 - 134.
10Bakan AA, Inci E, Bakan S, et al. Utility of diffusion-weighted imaging in the evaluation of liver fibrosis[ J]. Eur Radiol. 2011,22(3) :682 - 687.
6Corpeehot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC [ J]. Hepatology ,2006,43 ( 5 ) : 1118-1124.
7de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C viruscoinfected patients [ J ]. J Acquir Immune Defic Syndr, 2006, 41 (2) :175-179.
8Bonis PA, Friedman SL, Kaplan MM. Is liver fibmsis reversible? [J]. N Engl J Med,2001,344(6) :452-454.
9Bravo AA,Sheth SG, Chopra S. Liver biopsy [ J]. N Engl J Med, 2001,344(7 ) :495-500.
10Bedossa P, Dargere D, Paradis V, et al. Sampling variability of liver fibrosis in chronic hepatitis C [ J]. Hepatology ,2003,38 (6) :1449- 1457.
